HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding Patients
Targeted Oncology · 2026-05 · 21 (3) · 321-326
DOI: 10.1007/s11523-026-01215-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Targeted Oncology, online erschienen am 13.05.2026. Verfasst von Vivek Subbiah und 1 weiteren Autor:innen. Beteiligte Einrichtung: Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. viveksubbiah@outlook.com. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Erb-b2 Receptor Tyrosine Kinases, Lung Neoplasms. Die Arbeit nennt 18 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Bayer.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA. viveksubbiah@outlook.com.
- The US Oncology Network and Cancer Care Centers of Brevard, Orlando, FL, USA.
Förderung
- Bayer
Zitieren
APA
Subbiah, V., & Dietrich, M. (2026). HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding Patients. Targeted Oncology, 21(3), 321-326. https://doi.org/10.1007/s11523-026-01215-2
Vancouver
Subbiah V, Dietrich M. HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding Patients. Targeted Oncology. 2026;21(3):321-326. doi:10.1007/s11523-026-01215-2
BibTeX
@article{Subbiah2026,
author = {Subbiah, Vivek and Dietrich, Martin},
title = {HER2-Mutant Non-Small Cell Lung Cancer Podcast: Finding Patients},
journal = {Targeted Oncology},
year = {2026},
volume = {21},
number = {3},
pages = {321--326},
doi = {10.1007/s11523-026-01215-2}
}
EUVIMED